
CAS 1242137-15-0
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 prodotti.
Enzalutamide Carboxylic Acid Metabolite (M1)
CAS:Formula:C20H13F4N3O3SPurezza:98%Colore e forma:SolidPeso molecolare:451.3941Ref: IN-DA00A19I
1gPrezzo su richiesta5gPrezzo su richiesta25mg158,00€50mg186,00€100mg224,00€250mg517,00€4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic Acid
CAS:4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic AcidPurezza:98%Peso molecolare:451.39g/molEnzalutamide Carboxylic Acid Metabolite (M1)
CAS:Formula:C20H13F4N3O3SColore e forma:White To Off-White SolidPeso molecolare:451.40Enzalutamide carboxylic acid
CAS:<p>Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) .</p>Formula:C20H13F4N3O3SPurezza:97.88%Colore e forma:SolidPeso molecolare:451.39Enzalutamide Carboxylic Acid
CAS:<p>Applications Enzalutamide Carboxylic Acid is used as hormone therapies to prevent androgen-fuled growth of castrate-resistant prostate cancer.<br>References Tomasz, M.B., et al.: New Engl, J. Med., 424, 371 (2014);<br></p>Formula:C20H13F4N3O3SColore e forma:NeatPeso molecolare:451.39Ref: 10-F843830
1g3.482,00€1mg99,00€5mg199,00€10mg297,00€25mg386,00€50mg624,00€100mg933,00€250mg1.742,00€Enzalutamide Carboxylic Acid
CAS:<p>Enzalutamide Carboxylic Acid is a potent n-oxide derivative of Enzalutamide, which is used in the treatment of metastatic castration-resistant prostate cancer. It works by blocking the androgen receptor, thereby inhibiting the growth and spread of prostate cancer cells. Enzalutamide Carboxylic Acid is a carboxylic acid metabolite of Enzalutamide and abiraterone acetate. It has been shown to be effective in treating patients with castration-resistant prostate cancer who have failed previous treatments. This drug is also used in combination with other medications to treat metastatic castration-resistant prostate cancer. Enzalutamide Carboxylic Acid sulfate has been identified as a potential biomarker for predicting response to therapy in patients with metastatic castration-resistant prostate cancer.</p>Formula:C20H13F4N3O3SPurezza:Min. 95%Peso molecolare:451.39 g/molRef: ST-EA-CP-E16007
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta







